Metformin in gastrointestinal cancers and inflammatory bowel disease: Unraveling its mechanisms and therapeutic applications

Key Points

• Metformin shows promise in therapeutic applications for gastrointestinal cancers and inflammatory bowel disease.
• Key evidence includes significant modulation of pathways involved in cancer cell metabolism and inflammation.
• The analysis investigates the molecular mechanisms underlying metformin's effects on these diseases.
• Findings highlight the need for further exploration of metformin's role in treatment strategies.